New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: EarthLink, Inc (NASDAQ:ELNK), Rambus Inc (NASDAQ:RMBS), Extreme Networks, Inc (NASDAQ:EXTR), Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
EarthLink, Inc (NASDAQ:ELNK) showed a volume of 1.32 million shares by the end of last trade whereas the average volume of the stock remained 1.02 million shares. The stock opened the session at $5.37 but then moved to $5.12. At that price, the stock showed a negative performance of -4.30%. EarthLink Holdings Corp, formerly EarthLink, Inc., is a network, communications and information technology (IT) services provider to business and residential customers in the United States. The Company operates in two segments: Business Services and Consumer Services. EarthLink’s Business Services segment provides a range of data, voice, managed IT and equipment services to business customers. Its Consumer Services segment provides nationwide Internet access and related value-added services to residential customers.
Will ELNK Get Buyers Even After The Recent Rally? Find Out Here
Rambus Inc (NASDAQ:RMBS) opened the session at $8.71 and closed the session at $8.69. The stock showed a negative performance of -0.57% in previous trading session. Traded with volume of 1.56 million shares in the prior session and the average volume of the stock remained 1.35 million shares. Rambus Inc. (Rambus) is a technology solutions company. The Company invents, develops, offers and licenses solutions that challenge and enable its customers to create the future. It also develops products and services in security, advanced LED lighting and displays, and immersive mobile media. The Company has four business units: Memory and Interfaces Division, or MID,
Has RMBS Found The Bottom And Ready To Gain Momentum? Find Out Here
Extreme Networks, Inc (NASDAQ:EXTR) opened the session at $7.37 and closed the session at $7.44. The stock showed a positive performance of 1.50% in previous trading session. Traded with volume of 1.32million shares in the prior session and the average volume of the stock remained 1.11 million shares. The beta of the stock remained 1.67. Extreme Networks, Inc. together with its subsidiaries, is a provider of network infrastructure equipment and services for enterprises, data centers, and service providers. The Company’s customers include businesses, hospitals, schools, hotels, telecommunications companies and government agencies globally. The Company sells its products through an ecosystem of the Company channel partners who combine its Ethernet products with their offerings to create compelling information technology solutions for end user customers.
Why Should Investors Buy EXTR After The Recent Gain? Just Go Here and Find Out
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) the stock advanced 0.18% and finished the session at $5.61. Traded with volume of 1.32 million shares in the prior session and the average volume of the stock remained 696,089.00 shares. The beta of the stock remained -0.31. Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases,
Will SGYP Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)